Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway

BACKGROUND: Thyroid cancer is the most common type of endocrine malignancy and the incidence rate is rapidly increasing worldwide. Epigallocatechin-3-gallate (EGCG) could suppress cancer growth and induce apoptosis in many types of cancer cells. However, the mechanism of action of EGCG on the growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dongdong, Liu, Zhengguo, Li, Jianmei, Zhang, Qianqian, Zhong, Peiyu, Teng, Tieshan, Chen, Mingliang, Xie, Zhongwen, Ji, Ailing, Li, Yanzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394055/
https://www.ncbi.nlm.nih.gov/pubmed/30858760
http://dx.doi.org/10.1186/s12935-019-0762-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394055/
https://www.ncbi.nlm.nih.gov/pubmed/30858760
http://dx.doi.org/10.1186/s12935-019-0762-9

Ejemplares similares